BE803568A - Composition et methode destinees a favoriser la synthese des proteines et la suppression de la formation d'uree dans l'organisme - Google Patents

Composition et methode destinees a favoriser la synthese des proteines et la suppression de la formation d'uree dans l'organisme

Info

Publication number
BE803568A
BE803568A BE2052989A BE2052989A BE803568A BE 803568 A BE803568 A BE 803568A BE 2052989 A BE2052989 A BE 2052989A BE 2052989 A BE2052989 A BE 2052989A BE 803568 A BE803568 A BE 803568A
Authority
BE
Belgium
Prior art keywords
suppression
proteins
synthesis
promote
composition
Prior art date
Application number
BE2052989A
Other languages
English (en)
Original Assignee
Mackenzie Walser
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mackenzie Walser filed Critical Mackenzie Walser
Publication of BE803568A publication Critical patent/BE803568A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BE2052989A 1973-04-30 1973-08-14 Composition et methode destinees a favoriser la synthese des proteines et la suppression de la formation d'uree dans l'organisme BE803568A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35532773A 1973-04-30 1973-04-30

Publications (1)

Publication Number Publication Date
BE803568A true BE803568A (fr) 1973-12-03

Family

ID=23397062

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2052989A BE803568A (fr) 1973-04-30 1973-08-14 Composition et methode destinees a favoriser la synthese des proteines et la suppression de la formation d'uree dans l'organisme

Country Status (2)

Country Link
BE (1) BE803568A (fr)
GB (1) GB1444621A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8803144L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Energisubstrat
FI20045395L (fi) * 2004-10-21 2006-04-22 Elmomed Ltd Oy Ravintoainelisä ja sen käyttö
IT1397446B1 (it) 2010-01-12 2013-01-10 Professional Dietetics Srl Compositions comprising amino acids for prevention and/or treatment of renal disorders.
JP2014512372A (ja) * 2011-04-18 2014-05-22 ネステク ソシエテ アノニム α−ＨＩＣＡ及びエイコサペンタエン酸を含有する栄養組成物

Also Published As

Publication number Publication date
GB1444621A (en) 1976-08-04

Similar Documents

Publication Publication Date Title
FR2274290A2 (fr) Medicament a base d'alpha-hydroxy-acides analogues d'amino-acides, en association avec des acides alpha-cetoniques analogues d'amino-acides, pour favoriser la synthese des proteines et supprimer la formation de l'uree dans l'organisme
FR2332263A1 (fr) Composes azotes de l'uree utilisables comme catalyseurs dans la synthese de polyurethannes
BE821019A (fr) Instrument pour l'hygiene et les soins des cavites du corps
BE805377A (fr) Nouvelles compositions pour lutter contre l'aspect gras et inesthetique de la chevelure et pour ameliorer l'apparence de la peau
BE810280A (fr) Purification de l'acide hydroxyacetique
BE803567A (fr) Composition et methode destinees a favoriser la synthese des proteines et la suppression de la formation d'uree dans l'organisme
BE823675A (fr) N-polyhydroxyalkylaminoacides utilisables dans des produits pour les soins et la protection de la peau
BE803392A (fr) Perfectionnements dans, ou se rapportant a, la separation et a la purification de l'iridium
BE803390A (fr) Perfectionnement dans, ou relatifs a, la separation et a la purification de metaux du groupe du platine et d'or
CA1027478A (fr) Methode servant a promouvoir la synthese des proteines et a prevenir la formation de l'uree dans le corps
BE744461A (fr) Perfectionnements relatifs au rearrangement catalytique d'alkylaromatiques
BE809722A (fr) Synthese d'acide-lactones et de leurs derives
BE835330A (fr) Purification de l'urokinase
BE781996A (fr) Preparation continue de l'ethylene-bis-diacetamide
BE803389A (fr) Perfectionnements dans ou se rapportant a la separation et la purification des metaux du groupe du platine et de l'or
BE820388A (fr) Perfectionnements au traitement des matieres proteiques
BE823245A (fr) Ameliorations du ou relatives au bosselage de stratifies decoratifs
BE797017A (fr) Nouveaux amides de l'acide apovincaminique
CH534515A (fr) Nouvelles compositions cosmétiques pour améliorer l'apparence de la peau
BE835358A (fr) Synthese de la 2 - deutero - 3 - fluoro - alanine racemique et de ses sels et produits intermediaires dans cette synthese
BE818528A (fr) Nouveaux esteramides et esterimides d'acides o-phenyl-thionophosphoriques ou -phosphoniques
BE833232A (fr) Perfectionnements au scellement d'elements portants sur des fondations
BE813026A (fr) Perfectionnements apportes au montage des cloisons dans les constructions
FR2332233A1 (fr) Perfectionnement au traitement d'effluents aqueux contenant des composes du soufre
BE801006A (fr) Synthese de l'acide n(5)-methyltetrahydrohomofolique et autres derives hydrogenes de l'acide homofolique

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: WALSER MACKENZIE

Effective date: 19840814